Overview

Financials

News Discussions Technicals Forecast Seasonals

ICCM fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

‪58.83 M‬USD

—

−0.29USD

2006

Eyal Shamir

icecure-medical.com

About

IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.

Ownership

‪‪56.57 M‬‬

Free Float shares

‪‪29.11 M‬‬ (51.46%)

Closely held shares

‪‪27.46 M‬‬ (48.54%)

Free Float shares

‪‪29.11 M‬‬ (51.46%)

Closely held shares

‪‪27.46 M‬‬ (48.54%)

Capital structure

Market cap

‪‪58.83 M‬‬

Debt

‪‪380.00 K‬‬

Cash & equivalents

‪‪6.04 M‬‬

Enterprise value

‪‪53.17 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary

‪‪58.83 M‬‬

Price to earning ratio (P/E)

—

Price to sales ratio (P/S)

18.14x

Market Cap

Net income

Revenue

Price to earning ratio (P/E)

—

Price to sales ratio (P/S)

18.14x

Valuation ratios

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

‪0.00‬

‪6.00‬

‪12.00‬

‪18.00‬

‪24.00‬

P/S

Growth and Profitability

Company’s recent performance and margins

Performance

‪−660%‬

‪−570%‬

‪−480%‬

‪−390%‬

‪−300%‬

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

‪‪−4.50 M‬‬

‪‪−3.00 M‬‬

‪‪−1.50 M‬‬

‪0.00‬

‪‪1.50 M‬‬

Revenue

Net income

Net margin %

Revenue to profit conversion

Revenue

COGS

Gross profit

Op expenses

Op income

Non-Op income/ expenses

Taxes & Other

Net income

‪‪−3.90 M‬‬

‪‪−2.60 M‬‬

‪‪−1.30 M‬‬

‪0.00‬

‪‪1.30 M‬‬

Revenue

COGS

Gross profit

Expenses & adjustments

Net income

‪‪−3.60 M‬‬

‪‪−2.40 M‬‬

‪‪−1.20 M‬‬

‪0.00‬

‪‪1.20 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business

Period: 2024

Disposables

Systems

Exclusive Distribution Agreement and Other Services

By country

Period: 2024

Other

United States

Japan

India

China

Israel

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

‪0.00‬

‪‪300.00 K‬‬

‪‪600.00 K‬‬

‪‪900.00 K‬‬

‪‪1.20 M‬‬

Actual

Estimate

Earnings

Next:Aug 18, 2025

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

‪−0.08‬

‪−0.06‬

‪−0.04‬

‪−0.02‬

‪0.00‬

Actual

Estimate

Dividends

Dividend yield, history and sustainability

No dividends

ICCM has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company

Debt level and coverage

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

‪‪−4.50 M‬‬

‪0.00‬

‪‪4.50 M‬‬

‪‪9.00 M‬‬

‪‪13.50 M‬‬

Debt

Free cash flow

Cash & equivalents

Financial position analysis

Short term

Long term

‪0.00‬

‪‪2.50 M‬‬

‪‪5.00 M‬‬

‪‪7.50 M‬‬

‪‪10.00 M‬‬

Assets

Liabilities